B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　― Relevance to Age-Related Left Ventricular Modeling in Japanese ―-Reference-Cited by-同舟云学术

B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　― Relevance to Age-Related Left Ventricular Modeling in Japanese ―

Published:2017 Issue:7 Volume:81 Page:1006-1013
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Harada Eisaku¹,Mizuno Yuji¹,Kugimiya Fumihito¹,Shono Makoto¹,Maeda Hiroyuki¹,Yano Naotsugu¹,Kuwahara Koichiro²,Yasue Hirofumi¹

Affiliation:

1. Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute

2. Department of Cardiovascular Medicine, Shinshu University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/81/7/81_CJ-16-1282/_pdf

Reference43 articles.

1. 1. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402–1412.

2. 2. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464–469.

3. 3. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195–203.

4. 4. Grantham JA, Burnett JC Jr. BNP: Increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation 1997; 96: 388–390.

5. 5. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–1847.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice;J PHARMACOL SCI;2023

2. Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice;Journal of Pharmacological Sciences;2023-06

3. Association between left ventricular geometry and global myocardial work in patients with heart failure with preserved ejection fraction: assessment using strain-pressure loop;The International Journal of Cardiovascular Imaging;2022-10-22

4. β-Blockers are associated with increased B-type natriuretic peptide levels differently in men and women in heart failure with preserved ejection fraction;American Journal of Physiology-Heart and Circulatory Physiology;2022-08-01

5. Cyclic GMP and PKG Signaling in Heart Failure;Frontiers in Pharmacology;2022-04-11